Zimmer Biomet Holdings, Inc. (ZBH)
After hours:
| Previous close | 121.23 |
| Open | 121.30 |
| Bid | 119.00 x 900 |
| Ask | 126.80 x 1100 |
| Day's range | 119.56 - 121.30 |
| 52-week range | 102.00 - 147.50 |
| Volume | |
| Avg. volume | 1,273,033 |
| Market cap | 24.724B |
| Beta (5Y monthly) | 1.03 |
| PE ratio (TTM) | 26.07 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.96 (0.80%) |
| Ex-dividend date | 26 Jun 2024 |
| 1y target est | N/A |
- PR Newswire
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2024. The cash dividend of $0.24 per share is payable on or about July 31, 2024 to stockholders of record as of the close of business on June 26, 2024.
- PR Newswire
Zimmer Biomet Publishes 2023 Sustainability Report
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today published its 2023 Sustainability Report which provides an overview of the company's environmental, social and governance (ESG) program, progress, and accomplishments. The report outlines Zimmer Biomet's formal commitment with Science Based Targets initiative (SBTi) to reach Net-Zero greenhouse gas (GHG) emissions by 2050 and aligns with the Sustainability Accounting Standards Board (SASB) framework and t
- PR Newswire
Zimmer Biomet Announces First Quarter 2024 Financial Results
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2024. The Company reported first quarter net sales of $1.889 billion, an increase of 3.2% over the prior year period, and an increase of 4.4% on a constant currency1 basis. Net earnings for the first quarter were $172.4 million, or $399.7 million on an adjusted1 basis.
